Equine PIVKA-Ⅱ antibody and antigen (recombinant protein)

Diagnostic anti-Equine PIVKA-Ⅱ antibodies pairs and antigen for animal health (animal Equine/Horse hepatocellular carcinoma) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-PIVKA-Ⅱ-Ag01Equine PIVKA-Ⅱ$3090.00
GMP-EQU-PIVKA-Ⅱ-Ab01Anti-Equine PIVKA-Ⅱ mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-PIVKA-Ⅱ-Ab02Anti-Equine PIVKA-Ⅱ mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-PIVKA-Ⅱ-Ab03Anti-Equine PIVKA-Ⅱ human monoclonal antibody (mAb)$3090.00
GMP-EQU-PIVKA-Ⅱ-Ab04Anti-Equine PIVKA-Ⅱ human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-PIVKA-Ⅱ-Ag01
Product NameEquine PIVKA-Ⅱ
Target/BiomarkerEquine PIVKA-Ⅱ
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine PIVKA-Ⅱ antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PIVKA-Ⅱ level test of animal Equine/Horse with hepatocellular carcinoma.
TagHis
Reconized/Reactive SpecicsEquine PIVKA-Ⅱ
Product descriptionRecombinant Equine PIVKA-Ⅱ protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-PIVKA-Ⅱ-Ab01,GMP-EQU-PIVKA-Ⅱ-Ab02
Target/BiomarkerEquine PIVKA-Ⅱ
Product NameAnti-Equine PIVKA-Ⅱ mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine PIVKA-Ⅱ antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PIVKA-Ⅱ antibodies in Equine PIVKA-Ⅱ level test of animal Equine/Horse with hepatocellular carcinoma.
Product descriptionAnti-Equine PIVKA-Ⅱ mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PIVKA-Ⅱ antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-PIVKA-Ⅱ-Ab03,GMP-EQU-PIVKA-Ⅱ-Ab04
Target/BiomarkerEquine PIVKA-Ⅱ
Product NameAnti-Equine PIVKA-Ⅱ human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine PIVKA-Ⅱ antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PIVKA-Ⅱ antibodies in Equine PIVKA-Ⅱ level test of animal Equine/Horse with hepatocellular carcinoma.
Product descriptionAnti-Equine PIVKA-Ⅱ mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine PIVKA-Ⅱ, a captivating biomarker, takes on a pivotal role in the realm of equine health. Unique to horses, the significance of this biomarker lies in its association with coagulation abnormalities and Vitamin K-dependent clotting factors. Equine PIVKA-Ⅱ serves as a marker that reflects the intricate relationship between hemostasis, liver function, and the synthesis of clotting factors.

    The presence of Equine PIVKA-Ⅱ is intrinsically linked to the activation of coagulation factors, especially those that rely on Vitamin K. When Vitamin K metabolism faces challenges, the levels of Equine PIVKA-Ⅱ may rise, signifying the body's endeavor to maintain normal hemostasis despite compromised clotting factors. Additionally, alterations in Equine PIVKA-Ⅱ levels can indicate potential liver dysfunction, given the liver's central role in clotting factor and Vitamin K synthesis.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.